IRIS
SPAGNUOLO, ROCCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.620
AS - Asia 1.333
EU - Europa 1.139
SA - Sud America 385
OC - Oceania 45
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.555
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.543
SG - Singapore 565
IT - Italia 462
BR - Brasile 299
CN - Cina 227
DE - Germania 227
VN - Vietnam 208
IN - India 128
GB - Regno Unito 125
FI - Finlandia 109
SE - Svezia 50
NL - Olanda 46
CA - Canada 45
AU - Australia 37
AR - Argentina 33
HK - Hong Kong 24
IR - Iran 22
ID - Indonesia 21
MX - Messico 19
EC - Ecuador 18
KH - Cambogia 18
PL - Polonia 16
FR - Francia 14
IQ - Iraq 14
RO - Romania 14
BD - Bangladesh 13
MY - Malesia 12
TH - Thailandia 11
CL - Cile 10
JP - Giappone 10
RU - Federazione Russa 10
AT - Austria 9
CO - Colombia 9
NZ - Nuova Zelanda 8
PK - Pakistan 8
ES - Italia 7
TR - Turchia 7
ET - Etiopia 6
LV - Lettonia 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
SA - Arabia Saudita 5
UA - Ucraina 5
VE - Venezuela 5
YE - Yemen 5
GR - Grecia 4
IE - Irlanda 4
KR - Corea 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
TW - Taiwan 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
MA - Marocco 3
PE - Perù 3
BO - Bolivia 2
CH - Svizzera 2
CU - Cuba 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
LT - Lituania 2
MK - Macedonia 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 4.555
Salva come PNG Salva come JPEG
Città #
Singapore 255
Chandler 191
Munich 176
Ashburn 133
Dallas 129
San Jose 119
Bengaluru 94
Hefei 91
Milan 91
Ho Chi Minh City 90
Santa Clara 90
Helsinki 60
Chicago 59
London 57
Lawrence 50
Princeton 50
Catanzaro 47
Turku 41
Boardman 40
São Paulo 36
Hanoi 34
Beijing 31
New York 28
Rome 26
Council Bluffs 23
Los Angeles 23
Wilmington 23
Edinburgh 22
Hong Kong 20
Phnom Penh 18
Des Moines 16
Rio de Janeiro 15
Sydney 12
Redwood City 11
Mexico City 10
Palermo 10
Redmond 10
San Francisco 10
Amsterdam 9
Hamilton 9
Nuremberg 9
Toronto 9
Warsaw 9
Biên Hòa 8
Boston 8
Brooklyn 8
Christchurch 8
San Nicola Manfredi 8
Tokyo 8
Adelaide 7
Brisbane 7
Campinas 7
Chennai 7
Da Nang 7
Florence 7
Guayaquil 7
Hanover 7
Hải Dương 7
Shanghai 7
Turin 7
Brasília 6
Campo Bom 6
Fortaleza 6
Hortolândia 6
Jakarta 6
Montreal 6
Naples 6
Norwalk 6
Pattaya 6
Perth 6
Riga 6
Seattle 6
Taranto 6
Atlanta 5
Bari 5
Belo Horizonte 5
Buffalo 5
Catania 5
Collegeville 5
Curitiba 5
Delhi 5
Goiânia 5
Guangzhou 5
Horia 5
Jyväskylä 5
Kingston 5
Olomouc 5
Ottawa 5
Phoenix 5
Provo 5
Sanaa 5
Santiago de Cali 5
Stockholm 5
Verona 5
Washington 5
Assago 4
Athens 4
Bangkok 4
Belgrade 4
Berlin 4
Totale 2.619
Salva come PNG Salva come JPEG
Nome #
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 291
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 240
BETA-GLUCAN, INOSITOL AND DIGESTIVE ENZYMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH IRRITABLE BOWEL SYNDROME 228
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 106
Anti interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report. 71
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 68
The role of gluten-free diet in nonalcoholic fatty liver disease development 68
Acceptability of endoscopic procedures and patients' willingness to repeat them: a single-centre nursing study of influential factors 67
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 66
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 66
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 64
Patient Reported Outcomes come strumento infermieristico nella gestione delle Malattie Infiammatorie Croniche Intestinali (MICI): Sintomi Gastrointestinali e Alterazioni Psicosociali. 64
COMPARISON BETWEEN DIFFERENT BOWEL PREPARATION REGIMENS FOR COLONOSCOPY: A SINGLE-CENTRE STUDY 62
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 62
L’epatopatia alcolica: dal danno alla terapia 61
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 61
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 59
Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia 58
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review 58
OUTCOME OF ARTHRALGIA IN A SUBGROUP OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTI-TNF-ALPHA. A SINGLE CENTRE STUDY 58
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 56
DIAPHRAGMATIC REHABILITATION IN GASTROOESOPHAGEAL REFLUX DISEASE 56
Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge 55
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 54
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 51
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 50
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 50
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 49
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 49
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 48
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 48
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. 48
C-reactive protein induces tissue factor expression and promotes smooth muscle cells and endothelial cell proliferation 48
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases 48
Impact of Nursing Interventions via Telephone and Email on the Quality of Life of Patients with Inflammatory Bowel Disease: Preliminary Results of a Comparative Observational Study 46
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 46
Nursing issues in enteral nutrition during prone position in critically ill patients: A systematic review of the literature 46
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 46
Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease 46
Psychometric evaluation of an Italian custom 4-item short form of the PROMIS anxiety item bank in immune-mediated inflammatory diseases: An item response theory analysis 46
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 45
OBSERVING THE INFLUENCE OF SHAME AND GUILT IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW 45
Nursing communication as a tool for patient satisfaction. A single hospital survey 45
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. 45
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 45
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 44
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies 44
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 44
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 44
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 44
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 43
The role of Neopterin in cardiovascular disease 43
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 42
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 41
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 41
W1173 An In Vivo Study to Evaluate {MLCK} Expression in Patients with Inflammatory Bowel Diseases 40
Effect of excess body weight on the genetic susceptibility to cancer. 40
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 40
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 39
Surgery for a gastric Dieulafoy's lesion reveals an occult bleeding jejunal diverticulum. A case report. 39
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 39
Lived Experiences of Patients With Inflammatory Bowel Disease in Italy: A Phenomenological Investigation 39
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 39
Visualization of Comorbidities in Inflammatory Bowel Diseases through Networks 38
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 37
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 37
HIGH DIAGNOSTIC YIELD OF HISTOLOGICAL ANALYSIS OF EUS FINE-NEEDLE ASPIRATION BIOPSY INCLUDED IN FORMALIN WITHOUT ON-SITE CYTOPATHOLOGIC EXAMINATION. A RETROSPECTIVE STUDY 37
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 37
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 36
Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 34
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 34
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 33
Milk thistle, Sylibum marianum 33
Pro-atherothrombotic effects of sigarette smoking in endothelial cells. Protective effects of statins 33
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 33
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 31
Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review 31
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 30
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 30
Milk Thistle, Silybum marianum 30
Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: A nursing-led cross-sectional study of patients in clinical remission 30
Esophageal rupture after Heimlich maneuver: a case report and literature review 29
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 29
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study 29
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 27
MBOAT7 in liver and extrahepatic diseases 25
Cross talk between liver and adipose tissue: A new role for PNPLA3? 23
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 22
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 21
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 20
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 20
I disturbi funzionali del tratto digestivo superiore: aspetti epidemiologici, clinici e terapeutici 6
Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension 5
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features 5
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties 4
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 4
Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study 3
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis 3
Totale 4.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 17 13 41 5 4 13
2021/2022208 7 1 6 41 16 8 9 39 15 35 22 9
2022/2023672 104 52 23 64 56 47 19 73 86 47 64 37
2023/2024552 94 68 49 32 41 94 25 44 22 14 15 54
2024/20251.288 139 41 39 44 94 148 127 77 158 41 144 236
2025/20261.738 168 276 309 414 280 134 157 0 0 0 0 0
Totale 4.713